Japanese

Reevaluation of systemic corticosteroid in the treatment of Behçet disease Gakushi Matsu-ura 1 , Hiroshi Goto 1 , Toshihiro Ichikawa 1 , Suguru Matsuzawa 1 , Jun-ichi Sakai 1 , Masahiko Usui 1 1Dept of Ophthalmol, Tokyo Med Coll pp.670-674
Published Date 1998/4/15
DOI https://doi.org/10.11477/mf.1410905832
  • Abstract
  • Look Inside

We evaluated the value of systemic corticosteroid in the treatment of 61 cases of Behçet disease with ocular manifestations. Systemic corticosteroid was administered to 20 cases. The other 41 cases were treated without corticosteroid. The follow-up period averaged 6 years 4 months. Regardless of the length of observation, the steroid-treated, cases showed poorer visual acuity than the other 41 cases. The steroid-treated cases showed an average of 2.5 ± 2.0 inflammatory ocular attacks in contrast to 1.5±2.7 attacks in the other 41 cases. The cases treated without corticosteroid with impaired visual acuity showed gradual increase in the frequency of ocular attacks. The findings show that systemic corticosteroid therapy is not indicated to Behçet disease with ocular manifestations when evaluated with the fate of visual acuity and frequency of ocular attacks as parameters.


Copyright © 1998, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有